Are ketamine and midazolam (Versed) infusions compatible when co-administered?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 22, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question

Ketamine and Midazolam (Versed) Infusions Are Compatible and Commonly Co-Administered

Yes, ketamine and midazolam (Versed) drips are compatible when co-administered. These medications can be safely used together for procedural sedation and have been extensively studied in combination, with evidence supporting both their physical compatibility in solution and their clinical safety profile.

Physical Compatibility

The medications are chemically compatible when mixed in standard IV solutions. Ketamine (500 mg/L) and midazolam (45 mg/L) remain stable together in NaCl 0.9%, fructose 5%, and glucose 5% solutions for up to 24 hours without significant degradation 1. UV/VIS spectroscopy, IR spectroscopy, and HPLC analysis confirmed no concentration decrease within 100 hours (though use within 24 hours is recommended for safety).

Clinical Evidence for Co-Administration

Guideline Support

Multiple clinical practice guidelines explicitly support the combination:

  • The American Society of Anesthesiologists (2018) guidelines document that ketamine combined with midazolam provides effective sedation 2. Studies show equivocal findings for sedation scores, sedation time, recovery, and recovery agitation when comparing the combination versus ketamine alone.

  • Emergency department guidelines (2005) provide Level I evidence that midazolam and ketamine in combination provide effective and safe procedural analgesia in adult ED patients 3. A prospective observational trial of 70 adult patients receiving 0.07 mg/kg IV midazolam followed by 2 mg/kg IV ketamine showed no episodes of hallucinations, delirium, or emergency reactions.

  • Pediatric sedation guidelines (2004) include Level I evidence from a double-blind RCT of 266 pediatric patients (ages 4.5 months to 16 years) showing that ketamine combined with midazolam provides equally effective sedation 4.

FDA Drug Label Information

The Versed (midazolam) FDA label explicitly addresses co-administration with ketamine 5:

  • "No significant adverse interactions with commonly used premedications or drugs used during anesthesia and surgery...have been observed in adults or pediatric patients"
  • The label notes that midazolam can be mixed in the same syringe with frequently used premedications
  • Important caveat: "In neonates, however, severe hypotension has been reported with concomitant administration of fentanyl" - this warning is specific to fentanyl, not ketamine

Key Clinical Considerations

Benefits of Co-Administration

Adding midazolam to ketamine reduces recovery agitation - the most clinically significant benefit:

  • In adults: Recovery agitation decreased from 25% to 8% (NNT = 6) 6
  • In pediatrics: A 2004 Level I study showed midazolam decreased emesis (9.6% vs 19.4%) 4

Adverse Effects to Monitor

The combination increases risk of mild hypoxia compared to ketamine alone:

  • One 2024 pediatric study showed increased hypoxia (5% vs 0%) with midazolam co-administration, though all episodes were mild and resolved with repositioning or supplemental oxygen 7
  • Desaturation rates in the landmark pediatric RCT: 7.3% with combination vs 1.6% with ketamine alone 4
  • Critical point: No cases of apnea or laryngospasm occurred in these studies

Age-specific consideration: In patients >10 years old, adding midazolam paradoxically increased recovery agitation (35.7% vs 5.7%) 4. This suggests the combination may be less beneficial in older children and adolescents.

Dosing When Co-Administered

From the evidence 5:

  • Midazolam should be dose-reduced when combined with ketamine - the FDA label states "the dosage of midazolam should be adjusted according to the type and amount of concomitant medications administered"
  • Typical studied doses: 0.05-0.1 mg/kg IV midazolam with 1-2 mg/kg IV ketamine
  • Titrate slowly with adequate time (3-5 minutes) between doses to assess peak CNS effect

Practical Algorithm for Co-Administration

  1. Ensure appropriate monitoring (pulse oximetry, capnography, dedicated personnel)
  2. Administer midazolam first (0.05-0.07 mg/kg IV in adults; 0.05-0.1 mg/kg in pediatrics)
  3. Wait 3-5 minutes for peak effect
  4. Follow with ketamine (1.5-2 mg/kg IV in adults; 1-2 mg/kg in pediatrics)
  5. Monitor for respiratory depression - have bag-mask ventilation immediately available
  6. Expect longer sedation time (approximately 3.5 minutes longer) but similar time to discharge 7

Critical Safety Warnings

  • Never use rapid bolus administration - both medications require slow titration
  • Respiratory monitoring is mandatory - the combination increases CNS depression
  • Have reversal agents available (flumazenil for midazolam, though not for ketamine)
  • Avoid in neonates receiving fentanyl due to severe hypotension risk 5
  • Consider ketamine alone in patients >10 years to avoid paradoxical agitation 4

The evidence overwhelmingly supports that these medications are both physically compatible in solution and clinically safe when co-administered with appropriate monitoring and dosing adjustments.

References

Related Questions

What are the differences between ketazolam and midazolam?
What is the appropriate dosing and regimen of ketamine, atropine, and midazolam for sedating an 8‑month‑old infant undergoing a chest CT?
What is the recommended ketamine dosing regimen for refractory status epilepticus in adults and children?
What is the recommended infusion rate for maintaining sedation with ketamine (intravenous anesthetic agent)?
What is the standard dosing regimen of midazolam for anxiety management during a ketamine infusion in adults?
What is the appropriate management for a patient with psoriasis who has recurrent severe ankle swelling and pain, negative imaging, a prior gout diagnosis despite normal uric acid levels, and has not responded to colchicine or indomethacin?
In a pregnant woman under 34 weeks gestation who received an initial antenatal corticosteroid course more than 7 days ago, what clinical scenarios warrant a repeat (rescue) course of steroids?
What is the role of aldosterone antagonists (e.g., spironolactone, eplerenone) in the management of heart failure?
In a patient with inability to mix food by hand (ideomotor apraxia), where is the lesion localized?
Does the patient have any cognitive impairment?
What antibiotics should be used as empiric therapy for a 48‑day‑old preterm infant (born at 29 weeks + 6 days, corrected gestational age 36 weeks) with fever and cerebrospinal fluid findings suggestive of infection?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.